CTJ: Expanding Care with Precision Medicine with Jessica Gibson, CEO and Co-Founder of Ariel Precision Medicine
Genetic insights provide valuable information on the best way to approach a patient.
In this episode, Jessica Gibson discusses leveraging years of genetics data and AI technology to deliver precision medicine, particularly in metabolic and gastrointestinal diseases. She also discusses how the company addresses interoperability issues to deploy the precision medicine approach within the physician network.
Tune in to learn about precision medicine and its potential in care delivery!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
